In summary, in our experimental model, the lung allografts recapitulate features of BO alloimmune-dependent and airway inflammation–dependent fashion, with persistent elevation of IL-17A and CXCL1. The gene discussed is IL17A; the disease is bronchiolitis obliterans syndrome.